Ginkgo Bioworks

The synthetic biology platform company that programs cells like software. With a $1B valuation post-correction and 500+ customers, Ginkgo's cell engineering foundry is building the operating system for the biological economy, outperforming #2 Synthace by handling 3x more customer projects annually.